Furthermore, the characterisation of the circadian clock in leukaemia cells might further contribute to a deeper understanding of clock-related mechanisms in cancer on a more general level, potentially paving the way for the implementation of chronomodulated therapy strategies or clock specific cancer therapies in a clinical setting. Here, CLOCK is linked to leukemia.